| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Upregulated in MDS patients with U2AF1 mutations and confirmed as differentially expressed between U2AF1-mutated patients and healthy controls in an independent cohort. |
| Molecular mechanism: |
No circUBAP2-specific mechanism was experimentally defined; article suggests U2AF1 mutations may alter circRNA biogenesis during splicing. |
| Biological pathway or process: |
not specified |
| Detected method: |
S
|
| Validation methods: |
RNA-seq; Clinical Sample Validation; Bioinformatics Analysis |
| Clinical significance: |
Potential biomarker and therapeutic target investigation in U2AF1-mutated MDS. |
| Description: |
circUBAP2 was identified as one of seven circRNAs significantly upregulated in U2AF1-mutated MDS and also differentially expressed in an independent cohort. No circUBAP2-specific functional mechanism was tested. |
| Confidence score: |
0.348 |